Chinese Peptide Company, a subsidiary of MEDTIDE Inc. (03880.HK), is a peptide and oligonucleotide-focused Contract Research, Development, and Manufacturing Organization (CRDMO), offering full-cycle services ranging from early-stage discovery, pre-clinical research and clinical development to commercial-stage production.